Dermcast.tv

FDA

FDA Requires Black Box Warning on Tanning Beds Nation-Wide

In order to inform and protect consumers from the risks of sunlamp products such as tanning beds, the FDA is changing the classification and requiring a black box warning to be clearly visible on each indoor tanning device. The warning will emphasize the heighten risk for those younger than 18 or for people with a family history of skin cancer, and include language advising regular skin cancer evaluations for persons repeatedly exposed to UV radiation. 

FDA Approves New Drug for Psoriatic Arthritis

In a statement released on March 21, 2014, the U.S Food and Drug Administration announced that the FDA approved a new drug to treat adults with active psoriatic arthritis (PsA). The new drug is “Otezla”, and Bill Berkot, in “Update 2- U.S.

FDA Approves New Drug for Tinea Corporis

The FDA recently approved a new drug application to treat tinea corporis, tinea cruris, and tinea pedis. The drug is luliconazole, a topical azole antifungal cream.

Luliconazole is approved for a 1-week, once-daily treatment regimen treatment course in adults over 18 years old with tinea corporis or tinea cruris. Treatment for interdigital tinea pedis is once daily for 2 weeks. 

Product Theater- Sponsored by Valeant - Imiquimod 5% cream - Dr. Batiav

This podcast is on the use of Imiquimod 5% cream with Dr. Batiav and was recorded at the 2013 Summer SDPA Conference in St. Louis.
Syndicate content
Copyright © 2013 by SDPA - All Rights Reserved